Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2012
05/16/2012CN102459242A Phenoxymethyl heterocyclic compounds
05/16/2012CN102459216A Inhibitors of the renal outer medullary potassium channel
05/16/2012CN102459178A 2,5-disubstituted arylsulfonamide ccr3 antagonists
05/16/2012CN102459168A Novel indicator platform
05/16/2012CN102458581A N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
05/16/2012CN102458411A 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
05/16/2012CN102453034A Green synthesis method of copper phthalocyanine
05/16/2012CN102453033A Method for producing hydantoin derivative
05/16/2012CN102452873A Compound containing carbon or oxygen isotope and preparation method thereof and application thereof and composition thereof
05/16/2012CN101490054B Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
05/15/2012USRE43390 Pleuromutilin derivatives as antimicrobials
05/15/2012US8178689 Tricyclic compounds
05/15/2012US8178668 2-aminopyridine kinase inhibitors
05/15/2012US8178664 Preparation of metal mesoporphyrin compounds
05/15/2012US8178557 Compounds and methods of use
05/15/2012US8178554 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
05/15/2012US8178545 Dual small molecule inhibitors of cancer and angiogenesis
05/15/2012US8178543 Bi- and tricyclic fused pyrimidines as tyrosine kinase inhibitors
05/15/2012US8178534 cMET inhibitors
05/15/2012US8178533 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
05/15/2012US8178530 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
05/15/2012US8178525 FXA inhibitors with cyclic amidoxime or cyclic amidrazone as P4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
05/15/2012US8178523 Compounds for the treatment of hepatitis C
05/15/2012US8178470 Adducts of amines and polycarboxylic acids, and filter media comprising such adducts
05/15/2012CA2547347C Diazaindole-dicarbonyl-piperazinyl antiviral agents
05/15/2012CA2518620C 2,4,6-phenyl substituted cyclic ketoenols
05/10/2012WO2012061565A1 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
05/10/2012WO2012061529A1 Novel coelenterazine substrates and methods of use
05/10/2012WO2012061477A1 Coelenterazine derivatives and methods of using same
05/10/2012WO2012061342A2 Substituted benzo-imidazo-pyrido-diazepine compounds
05/10/2012WO2012059869A1 Gpr17-modulating compounds, diagnostic and therapeutic uses thereof
05/10/2012WO2012059584A1 High-efficiency catalysts, preparation and use thereof
05/10/2012WO2012059568A1 Novel water-soluble indolobenzazepine molecules demonstrating antimitotic, antivascular, and antitumor activities in vivo
05/10/2012WO2012059507A1 Pyrrolidine derivatives used as cathepsin inhibitors
05/10/2012WO2012059171A1 7-([1,2,3]triazol-4-yl)-pyrrolo[2,3-b]pyrazine derivatives
05/10/2012WO2012019430A8 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
05/10/2012WO2012019427A8 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
05/10/2012WO2012019426A8 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
05/10/2012WO2011031818A3 Histamine h3 inverse agonists and antagonists and methods of use thereof
05/10/2012US20120117667 Novel coelenterazine substrates and methods of use
05/10/2012US20120116076 Switchable solvents and methods of use thereof
05/10/2012US20120115901 Porphyrin compounds comprising one or more pyridone moieties
05/10/2012US20120115895 Tricyclic indole-derived spiro derivatives as crth2 modulators
05/10/2012US20120115878 Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
05/10/2012US20120115863 Compounds for the treatment of cns disorders
05/10/2012US20120115852 Heterocyclic compounds as autotaxin inhibitors
05/10/2012US20120115848 Inhibitors of Polo-Like Kinase
05/10/2012US20120115820 Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
05/10/2012US20120114739 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
05/10/2012US20120112629 Material for organic electroluminescence device and organic electroluminescence device using the same
05/10/2012US20120111411 Fullerene derivative
05/10/2012CA2816808A1 High-efficiency catalysts, preparation and use thereof
05/10/2012CA2816363A1 7-(1,2,3-triazol-4-yl)pyrrolo[2,3-b]pyrazine derivatives
05/10/2012CA2815611A1 Pyrrolidine derivatives used as cathepsin inhibitors
05/10/2012CA2815381A1 Coelenterazine derivatives and methods of using same
05/10/2012CA2815227A1 Novel coelenterazine substrates and methods of use
05/10/2012CA2815084A1 Cdk inhibitors
05/09/2012EP2448942A1 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS
05/09/2012EP2448941A2 Pyrazolopyrimidine jak inhibitor compounds and methods
05/09/2012EP2448940A2 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
05/09/2012EP2448939A1 Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof
05/09/2012EP2448926A1 Flavin derivatives
05/09/2012EP2448585A1 Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
05/09/2012EP2318413B1 Pyrrolobenzodiazepines
05/09/2012EP2244701B1 Corroles for neuroprotection and neurorescue
05/09/2012EP1888589B1 Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods
05/09/2012EP1423107B1 Fatty alcohol drug conjugates
05/09/2012CN102448963A Useful pharmaceutical salts of 7-[(3r, 4r)-3-hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-one
05/09/2012CN102448960A Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-carboxylic acid amides
05/09/2012CN102448958A Pyrimddinyl and 1,3,5-triazinyl benzimtoazole sulfonamides and their use in cancer therapy
05/09/2012CN102448946A Materials for organic electroluminescent devices
05/09/2012CN102448941A Substituted isoquinoline derivative
05/09/2012CN102443015A 7-substituted quinoline carboxylic acid derivatives, preparation method and application thereof in antibiosis and antituberculosis
05/09/2012CN102443008A Hydrothermal synthesis method of copper phthalocyanine
05/09/2012CN102443007A Process for extracting chlorophyll
05/09/2012CN101863892B Preparation mothod of epibatidine and analogues thereof
05/09/2012CN101300260B Method for synthesizing spiro quaternary ammonium systems
05/09/2012CN101213195B Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
05/09/2012CN101081851B Preparation method of alpha-aza toroid drug template
05/08/2012US8173813 selectively inhibit neuronal nitric oxide synthase in combination with other pharmaceutically active agents; antidepressants
05/08/2012US8173803 Supramolecular scaffolds and methods of making the same
05/08/2012US8173800 Luminescent macrocyclic lanthanide complexes
05/08/2012US8173662 Fused pyrimidines as inhibitors of nucleoside phosphorylases and nucleosidases
05/08/2012US8173661 Alpha-IIB-beta-3 inhibitors and uses thereof
05/08/2012US8173657 Imidazoquinoxaline compounds as immunomodulators
05/08/2012US8173656 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
05/08/2012US8173654 Triazolopyridazine compounds
05/08/2012US8173646 FAB I inhibitors
05/08/2012US8173630 Multipodal tethers for high-density attachment of redox-active moieties to substrates
05/08/2012US8173107 Delivery of antipsychotics through an inhalation route
05/08/2012CA2631664C 9-membered heterobicyclic compounds as inhibitors of protein kinases
05/03/2012WO2012058031A2 Novel method for preparation of bisnorcymerine and salts thereof
05/03/2012WO2012057247A1 Fused aminodihydropyrimidine derivative
05/03/2012WO2012056285A1 An improved process for the preparation of pemetrexed
05/03/2012US20120108811 Process for preparing temozolomide
05/03/2012US20120108634 Farnesyl protein transferase inhibitor combinations with antiestrogen agents
05/03/2012US20120108612 Inhibitors of bruton's tyrosine kinase
05/03/2012US20120108604 Processes for preparing amine salts of sildenafil-analogues and use thereof
05/03/2012US20120108598 Sitagliptin synthesis
05/03/2012US20120108597 Azaquinazolinediones Chymase Inhibitors
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 573